Published June 18, 2018
| Version v1
Journal article
Open
Optimisation of an ALP assay in C2C12 cells 20180618
Description
A method for optimising the amount of BMP-7 that needs to be added to the C2C12 myoblast cell line in order to increase the expression of alkaline phosphatase (as an indication of BMP signalling activity) sufficiently to be detected by using 4-methylumbelliferyl (4-MUP) as a fluorogenic substrate.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
Optimisation_of_an_alkaline_phosphatase_assay_20180606.pdf
Files
(960.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:0ef660ec9e2ec6c3d1cea6a3e82a792b
|
386.8 kB | Download |
|
md5:33be54236f456ff7f0530eebd5938599
|
573.8 kB | Preview Download |